Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries.
Graham DJ, Izurieta HS, Zhang D, Avagyan A, Lyu H, Wiederhorn R, Lu Y, Mosholder AD, Smith ER, Zhao Y, Shangguan S, Tsai HT, Pennap D, Sandhu AT, Wernecke M, MaCurdy TE, Kelman JA, Forshee RA. Graham DJ, et al. Among authors: izurieta hs. Am J Med. 2023 Oct;136(10):1018-1025.e3. doi: 10.1016/j.amjmed.2023.07.003. Epub 2023 Jul 15. Am J Med. 2023. PMID: 37454868
Reduced Risk of SARS-CoV-2 Infection Among Household Contacts with Recent Vaccination and Past COVID-19 Infection: Results from Two Multi-Site Case-Ascertained Household Transmission Studies.
Rolfes MA, Talbot HK, Morrissey KG, Stockwell MS, Maldonado Y, McLean HQ, Lutrick K, Bowman NM, Rao S, Izurieta HS, Zhu Y, Chappell J, Battan-Wraith S, Merrill LS, McClaren S, Sano E, Petrie JG, Biddle J, Johnson S, Salvatore P, Smith-Jeffcoat SE, Asturias EJ, Lin JT, Ellingson KD, Belongia EA, Olivo V, Mellis AM, Grijalva CG; Respiratory Virus Transmission Network Study Group. Rolfes MA, et al. Among authors: izurieta hs. Am J Epidemiol. 2024 Aug 31:kwae334. doi: 10.1093/aje/kwae334. Online ahead of print. Am J Epidemiol. 2024. PMID: 39218430
Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries.
Mosholder AD, Izurieta HS, Zhang R, Shangguan S, Lu Y, Akhtar S, Wernecke M, He J, Chillarige Y, Feng Y, Avagyan A, Leishear K, Forshee RA, MaCurdy TE, Kelman JA, Graham DJ. Mosholder AD, et al. Among authors: izurieta hs. Pharmacotherapy. 2024 Oct;44(10):803-810. doi: 10.1002/phar.4614. Epub 2024 Oct 18. Pharmacotherapy. 2024. PMID: 39425479
Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods.
Lu Y, Lindaas A, Matuska K, Izurieta HS, McEvoy R, Menis M, Shi X, Steele WR, Wernecke M, Chillarige Y, Wong HL, Kelman JA, Forshee RA. Lu Y, et al. Among authors: izurieta hs. Open Forum Infect Dis. 2024 Jan 29;11(3):ofae051. doi: 10.1093/ofid/ofae051. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38505296 Free PMC article.
The Brighton collaboration standardized module for vaccine benefit-risk assessment.
Levitan B, Hadler SC, Hurst W, Izurieta HS, Smith ER, Baker NL, Bauchau V, Chandler R, Chen RT, Craig D, King J, Pitisuttithum P, Strauss W, Tomczyk S, Zafack J, Kochhar S. Levitan B, et al. Among authors: izurieta hs. Vaccine. 2024 Feb 6;42(4):972-986. doi: 10.1016/j.vaccine.2023.09.039. Epub 2023 Dec 21. Vaccine. 2024. PMID: 38135642 Free article.
Benefit-risk assessment of vaccines.
Kochhar S, Izurieta HS, Chandler RE, Hacker A, Chen RT, Levitan B. Kochhar S, et al. Among authors: izurieta hs. Vaccine. 2024 Feb 6;42(4):969-971. doi: 10.1016/j.vaccine.2023.07.041. Epub 2023 Aug 8. Vaccine. 2024. PMID: 37563049 Free article.
77 results